Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Single-cell RNA sequencing in ovarian cancer: decoding the tumor microenvironment for personalized therapy.

Journal of ovarian research·2026

Same author

Engineered small extracellular vesicles in hematologic malignancies: mechanisms, therapeutic strategies, and translational challenges.

Clinical and experimental medicine·2026

Same author

MicroRNA-SIRT1 crosstalk in liver diseases: molecular regulation of metabolism, inflammation, and cell survival.

Molecular biology reports·2026

Same author

Engineering microspheres for breast cancer: integrating tumor modeling, diagnostics, and targeted treatment.

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences·2026

Same author

Exploring 14-3-3ζ: insights into its role in cancer mechanisms and future therapeutic applications.

Hereditas·2026

Same author

Updates on niosomes in interfering nucleic acid delivery for cancer treatment: A comprehensive review and future perspectives.

Medical oncology (Northwood, London, England)·2026

Search research articles

Related Experiment Video

Updated: Jan 10, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Smart Biomaterials as Immunomodulators in Cancer Therapy.

Amit Sharma¹, Bhavin Parekh¹, Vinay Patil¹

¹Arnold and Marie Schwartz College of Pharmacy, Long Island University, Brooklyn, NY, USA.

|November 26, 2025

Summary

Smart biomaterials offer precise control over cancer immunotherapy by enabling localized drug delivery. These advanced materials enhance treatment efficacy and reduce side effects, paving the way for safer, personalized cancer therapies.

Keywords:

cancer immunotherapy immune modulation localised drug delivery smart biomaterials tumour microenvironment

More Related Videos

Author Spotlight: Efficient Detection of Immune Cell-Infiltration in Cancer Tissues Using Fluorescent Immunohistochemistry

Author Spotlight: Efficient Detection of Immune Cell-Infiltration in Cancer Tissues Using Fluorescent Immunohistochemistry

Published on: January 26, 2024

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Related Experiment Videos

Last Updated: Jan 10, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Author Spotlight: Efficient Detection of Immune Cell-Infiltration in Cancer Tissues Using Fluorescent Immunohistochemistry

Author Spotlight: Efficient Detection of Immune Cell-Infiltration in Cancer Tissues Using Fluorescent Immunohistochemistry

Published on: January 26, 2024

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Area of Science:

Biomaterials Science
Immunology
Oncology

Background:

Conventional immunotherapies face challenges like limited response rates, tumor heterogeneity, and systemic toxicities.
Smart biomaterials offer a solution by precisely modulating immune responses for enhanced cancer treatment.

Purpose of the Study:

To review the design and application of smart biomaterials as immunomodulators in cancer therapy.
To highlight how these materials overcome clinical barriers in immunotherapy.

Main Methods:

Engineered biomaterials (liposomes, nanoparticles, hydrogels, etc.) enable spatial and temporal control of therapeutic agent delivery.
These platforms improve drug retention, reduce systemic exposure, and minimize off-target effects.

Main Results:

Smart biomaterials enhance pharmacokinetics and biodistribution, facilitating tumor microenvironment crosstalk.
Innovations like mRNA lipid nanoparticles and responsive hydrogels show significant translational potential, with some advancing to clinical trials.

Conclusions:

Smart biomaterials represent a transformative approach to cancer immunotherapy, offering safer, more durable, and personalized treatments.
Continued innovation in materials science and immuno-oncology integration is key to reshaping cancer treatment landscapes.